Article info

Download PDFPDF

Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology

Authors

  1. Correspondence to Dr Sarosh R Irani, Oxford Autoimmune Neurology Group, Nuffield Dept of Clinical Neurosciences, University of Oxford, Oxford, UK; sarosh.irani{at}ndcn.ox.ac.uk
View Full Text

Citation

Binks S, Irani SR
Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology

Publication history

  • Received June 10, 2020
  • Revised June 19, 2020
  • Accepted June 22, 2020
  • First published July 10, 2020.
Online issue publication 
December 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.